Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Case of de novo psoriasis possibly triggered by nivolumab.

× No keyword cloud information.

9 in total

Review 1. Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors: Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal: Immunology Date: 2018-02-06 Impact factor: 7.397

2. Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern.

Authors: Genevieve J Kaunitz; Manisha Loss; Hira Rizvi; Sowmya Ravi; Jonathan D Cuda; Karen B Bleich; Jessica Esandrio; Inbal Sander; Dung T Le; Luis A Diaz; Julie R Brahmer; Charles G Drake; Travis J Hollmann; Mario E Lacouture; Matthew D Hellmann; Evan J Lipson; Janis M Taube
Journal: Am J Surg Pathol Date: 2017-10 Impact factor: 6.394

3. Ixekizumab for the treatment of erythrodermic psoriasis triggered by durvalumab-tremelimumab in a cancer patient.

Authors: Arrieta Vinaixa Aranzazu; Víctor Morillas-Lahuerta; María Blanco De Tord; José-Manuel Carrascosa Carrillo
Journal: Eur J Dermatol Date: 2021-08-26 Impact factor: 2.805

Review 4. Dermatologic toxicities to immune checkpoint inhibitor therapy: A review of histopathologic features.

Authors: Samantha R Ellis; Aren T Vierra; Jillian W Millsop; Mario E Lacouture; Maija Kiuru
Journal: J Am Acad Dermatol Date: 2020-04-29 Impact factor: 11.527

5. Anti-Programmed Cell Death-1-Induced Plaque and Guttate Psoriasis.

Authors: Toshiyuki Yamamoto
Journal: Indian J Dermatol Date: 2018 Jan-Feb Impact factor: 1.494

6. De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin's Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation.

Authors: Panayotis Kaloyannidis; Eshrak Al Shaibani; Miral Mashhour; Mohammed Gamil; Ioannis Apostolidis; Hani Al Hashmi; Khalid Ahmed Al Anazi
Journal: Case Rep Hematol Date: 2018-10-16

Review 7. The contribution of IL-17 to the development of autoimmunity in psoriasis.

Authors: Masutaka Furue; Takafumi Kadono
Journal: Innate Immun Date: 2019-05-24 Impact factor: 2.680

Review 8. Understanding the functional inflammatory factors involved in therapeutic response to immune checkpoint inhibitors for pan-cancer.

Authors: Yanmeizhi Wu; Shan Yu; Hong Qiao
Journal: Front Pharmacol Date: 2022-09-01 Impact factor: 5.988

9. Psoriasis Vulgaris Exacerbation during Treatment with a PD-1 Checkpoint Inhibitor: Case Report and Literature Review.

Authors: Marlies De Bock; Eva Hulstaert; Vibeke Kruse; Lieve Brochez
Journal: Case Rep Dermatol Date: 2018-08-09

9 in total